The Native Antigen Company
The Native Antigen Company has developed a proprietary HEK293 mammalian expression system (VirtuE) for expression of recombinant proteins. The Native Antigen Company has rapidly become one of the world’s leading suppliers of infectious disease reagents. Our portfolio of reagents continues to expand rapidly, and we are widely acknowledged to be a primary source of reagents and kits for the study of emerging diseases. Our infectious disease reagents are widely adopted by pharmaceutical, in vitro diagnostics and vaccine manufacturers, as well as leading academic groups in cutting-edge research, where correct folding and glycosylation of proteins is vital. We also offer our expertise on a contract basis to other sectors where highly purified proteins are required.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical / Health Care
- Market Focus:
- Globally (various continents)
- Year Founded:
- 2010
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About us
We’re a leading supplier of native and recombinant viral and bacterial antigens, antibodies and immunoassays, alongside bespoke custom and contract services.
We are an ethical and sustainable organisation and are proud of our long-term relationships with our customers and partners.
In addition to producing world-leading reagents for infectious disease, we believe we have a responsibility to our customers, our staff and to the planet to behave ethically and sustainably in running our business. We will always be open and honest in all of our communications with customers. We also strive to minimise our environmental footprint, exemplified by our use of 100% renewable energy, and recycled packaging wherever possible.